REFERENCES
1. World Health Organization. Obesity and Overweight. Available from https://www.who.int/topics/obesity/en/ [Last accessed on 28 Apr 2020].
2. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology 2007;132:2087-102.
3. Braghetto I, Korn O, Csendes A, Gutiérrez L, Valladares H, et al. Laparoscopic treatment of obese patients with gastroesophageal reflux disease and Barrett’s esophagus: a prospective study. Obes Surg 2012;22:764-72.
4. Prachand VN, Alverdy JC. Gastroesophageal reflux disease and severe obesity: Fundoplication or bariatric surgery? World J Gastroenterol 2010;16:3757-61.
5. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R; Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-20. quiz 1943
6. Kristo I, Paireder M, Jomrich G, Felsenreich DM, Nikolic M, et al. Modern esophageal function testing and gastroesophageal reflux disease in morbidly obese patients. Obes Surg 2019;29:3536-41.
7. Martinez SD, Malagon IB, Garewal HS, Cui H, Fass R. Non-erosive reflux disease (NERD)--acid reflux and symptom patterns. Aliment Pharmacol Ther 2003;17:537-45.
8. Yamasaki T, Fass R. Reflux hypersensitivity: a new functional esophageal disorder. J Neurogastroenterol Motil 2017;23:495-503.
9. Dickman R, Maradey-Romero C, Fass R. The role of pain modulators in esophageal disorders - no pain no gain. Neurogastroenterol Motil 2014;26:603-10.
10. Stein HJ, Liebermann-Meffert D, DeMeester TR, Schneider GT, Siewert JR. Three-dimensional pressure image and muscular structure of the human lower esophageal sphincter. Surgery 1995;117:692-8.
12. Patti MG, Gantert W, Way LW. Anatomy of the esophagus and gastroesophageal junction. Surg Clin North Am 1997;77:959-69.
14. Ayazi S, Hagen JA, Chan LS, DeMeester SR, Lin MW, et al. Obesity and gastroesophageal reflux: quantifying the association between body mass index, esophageal acid exposure, and lower esophageal sphincter status in a large series of patients with reflux symptoms. J Gastrointest Surg 2009;13:1440-7.
15. Pandolfino JE, El-Serag HB, Zhang Q, Shah N, Ghosh SK, et al. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology 2006;130:639-49.
16. Sugerman HJ, DeMaria EJ, Felton WL, Nakatsuka M, Sismanis A. Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri. Neurology 1997;49:507-11.
17. de Vries DR, van Herwaarden MA, Smout AJ, Samsom M. Gastroesophageal pressure gradients in gastroesophageal reflux disease: relations with hiatal hernia, body mass index, and esophageal acid exposure. Am J Gastroenterol 2008;103:1349-54.
18. Herbella FA, Sweet MP, Tesesco P, Nipomnick I, Patti MG. Gastroesophageal reflux disease and obesity. Pathophysiology and implications for treatment. J Gastrointest Surg 2007;11:286-90.
20. Ruigómez A, García Rodríguez LA, Wallander MA, Johansson S, Eklund S. Esophageal stricture: incidence, treatment patterns, and recurrence rate. Am J Gastroenterol 2006;101:2685-92.
21. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett’s) esophagus. N Eng J Med 1985;313:857-9.
22. Ronkainen J, Talley NJ, Storskrubb T, Johansson SE, Lind T, et al. Erosive esophagitis is a risk factor for Barrett’s esophagus: a community-based endoscopic follow-up study. Am J Gastroenterol 2011;106:1946-52.
23. Akiyama T, Yoneda M, Inamori M, Iida H, Endo H, et al. Visceral obesity and the risk of Barrett’s esophagus in Japanese patients with non-alcoholic fatty liver disease. BMC Gastroenterol 2009;9:56.
25. Corley DA, Kubo A, Levin TR, Block G, Habel L, et al. Abdominal obesity and body mass index as risk factors for Barrett’s esophagus. Gastroenterology 2007;133:34-41.
27. Rossi M, Barreca M, de Bortoli N, Renzi C, Santi S, et al. Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study. Ann Surg 2006;243:58-63.
28. Parrilla P, Martínez de Haro LF, Ortiz A, Munitiz V, Molina J, et al. Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett’s esophagus. Ann Surg 2003;237:291-8.
29. Chang EY, Morris CD, Seltman AK, O’Rourke RW, Chan BK, et al. The effect of antireflux surgery on esophageal carcinogenesis in patients with barrett esophagus: a systematic review. Ann Surg 2007;246:11-21.
30. Klinkenberg-Knol EC, Nelis F, Dent J, Snel P, Mitchell B, et al. Long-term omeprazole treatment in resistant gastro-esophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology 2000;118:661-9.
31. Marshall RE, Anggiansah A, Manifold DK, Owen WA, Owen WJ. Effect of omeprazole 20 mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barrett’s oesophagus. Gut 1998;43:603-6.
32. Waring JP. Postfundoplication complications. Prevention and management. Gastroenterol Clin North Am 1999;28:1007-19.
33. Spechler SJ. Does Barrett’s esophagus regress after surgery (or proton pump inhibitors)? Dig Dis 2014;32:156-63.
34. Adil MT, Al-Taan O, Rashid F, Munasinghe A, Jain V, et al. A systematic review and meta-analysis of the effect of roux-en-Y gastric bypass on Barrett’s esophagus. Obes Surg 2019;29:3712-21.
35. Braghetto I, Lanzarini E, Korn O, Valladares H, Molina JC, et al. Manometric changes of the lower esophageal sphincter after sleeve gastrectomy in obese patients. Obes Surg 2010;20:357-62.
36. Genco A, Soricelli E, Casella G, Maselli R, Castagneto-Gissey L, et al. Gastroesophageal reflux disease and Barrett’s esophagus after laparoscopic sleeve gastrectomy: a possible, underestimated long-term complication. Surg Obes Relat Dis 2017;13:568-74.
37. Soricelli E, Casella G, Baglio G, Maselli R, Ernesti I, et al. Lack of correlation between gastroesophageal reflux disease symptoms and esophageal lesions after sleeve gastrectomy. Surg Obes Relat Dis 2018;14:751-6.
38. Sebastianelli L, Benois M, Vanbiervliet G, Bailly L, Robert M, et al. Systematic endoscopy 5 years after sleeve gastrectomy results in a high rate of Barrett’s esophagus: results of a multicenter study. Obes Surg 2019;29:1462-9.
39. Felsenreich DM, Kefurt R, Schermann M, Beckerhinn P, Kristo I, et al. Reflux, sleeve dilation, and Barrett’s esophagus after laparoscopic sleeve gastrectomy: long-term follow-up. Obes Surg 2017;27:3092-101.
40. Shaheen NJ, Weinberg DS, Denberg TD, Chou R, Qaseem A, et al; Clinical Guidelines Committee of the American College of Physicians. Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians. Ann Intern Med 2012;157:808-16.
41. Levine MS, Rubesin SE. History and evolution of the barium swallow for evaluation of the pharynx and esophagus. Dysphagia 2017;32:55-72.
42. Howard PJ, Maher L, Pryde A, Cameron EW, Heading RC. Five year prospective study of the incidence, clinical features, and diagnosis of achalasia in Edinburgh. Gut 1992;33:1011-5.
44. Arber N, Grossman A, Lurie B, Hoffman M, Rubinstein A, et al. Epidemiology of achalasia in central Israel. Rarity of esophageal cancer. Dig Dis Sci 1993;38:1920-5.
45. Stefanidis D, Hope WW, Kohn GP, Reardon PR, Richardson WS, et al. Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc 2010;24:2647-69.
46. Saino G, Bonavina L, Lipham JC, Dunn D, Ganz RA. Magnetic sphincter augmentation for gastroesophageal reflux at 5 years: final results of a pilot study show long-term acid reduction and symptom improvement. J Laparoendosc Adv Surg Tech 2015;25:787-92.
47. Ganz RA, Edmundowicz SA, Taiganides PA, Lipham JC, Smith CD, et al. Long-term outcomes of patients receiving a magnetic sphincter augmentation device for gastroesophageal reflux. Clin Gastroenterol Hepatol 2016;14:671-7.
48. Perez AR, Moncure AC, Rattner DW. Obesity adversely affects the outcome of antireflux operations. Surg Endosc 2001;15:986-9.
49. Morgenthal CB, Lin E, Shane MD, Hunter JG, Smith CD. Who will fail laparoscopic Nissen fundoplication? Preoperative prediction of long-term outcomes. Surg Endosc 2007;21:1978-84.
50. Kellogg TA, Andrade R, Maddaus M, Slusarek B, Buchwald H, et al. Anatomic findings and outcomes after antireflux procedures in morbidly obese patients undergoing laparoscopic conversion to Roux-en-Y gastric bypass. Surg Obes Relat Dis 2007;3:52-7.
51. Angrisani L, Santonicola A, Iovino P, Vitiello A, Higa K, et al. IFSO worldwide survey 2016: primary, endoluminal, and revisional procedures. Obes Surg 2018;28:3783-94.
52. Gagner M, Deitel M, Erickson AL, Crosby RD. Survey on laparoscopic sleeve gastrectomy (LSG) at the Fourth International Consensus Summit on Sleeve Gastrectomy. Obes Surg 2013;23:2013-7.
53. Frezza EE, Ikramuddin S, Gourash W, Rakitt T, Kingston A, et al. Symptomatic improvement in gastroesophageal reflux disease (GERD) following laparoscopic Roux-en-Y gastric bypass. Surg Endosc 2002;16:1027-31.
54. Stefanidis D, Hope WW, Kohn GP, Reardon PR, Richardson WS, et al; SAGES Guidelines Committee. Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc 2010;24:2647-69.
55. Katz PO, Gerson LB, Vela MF. Guidelines for surgical treatment of gastroesophageal reflux disease. Am J Gastroenterol 2013;108:308-28.
56. Schietroma M, Piccione F, Clementi M, Cecilia EM, Sista F, et al. Short- and long-term, 11-22 years, results after laparoscopic nissen fundoplication in obese versus nonobese patients. J Obes 2017;2017:7589408.
57. Chiu S, Birch DW, Shi X, Sharma AM, Karmali S. Effect of sleeve gastrectomy on gastroesophageal reflux disease: a systematic review. Surg Obes Relat Dis 2011;7:510-5.
58. DuPree CE, Blair K, Steele SR, Martin MJ. Laparoscopic sleeve gastrectomy in patients with preexisting gastroesophageal reflux disease: a national analysis. JAMA Surg 2014;149:328-34.
59. Himpens J, Dobbeleir J, Peeters G. Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg 2010;252:319-24.
60. Oor JE, Roks DJ, Unlu C, Hazebroek EJ. Lap aroscopic sleeve gastrectomy and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Surg 2016;211:250-67.
61. Gu L, Chen B, Du N, Fu R, Huang X, et al. Relationship between bariatric surgery and gastroesophageal reflux disease: a systematic review and meta-analysis. Obes Surg 2019;29:4105-13.
62. Kavanagh R, Smith J, Bashir U, Jones D, Avgenakis E, et al. Optimizing bariatric surgery outcomes: a novel preoperative protocol in a bariatric population with gastroesophageal reflux disease. Surg Endosc 2020;34:1812-8.
63. Singh PM, Panwar R, Borle A, Goudra B, Trikha A, et al. Efficiency and safety effects of applying ERAS protocols to bariatric surgery: a systematic review with meta-analysis and trial sequential analysis of evidence. Obes Surg 2017;27:489-501.
64. Thorell A, MacCormick AD, Awad S, Reynolds N, Roulin D, et al. Guidelines for perioperative care in bariatric surgery: enhanced recovery after surgery (ERAS) society recommendations. World J Surg 2016;40:2065-83.
65. Małczak P, Pisarska M, Piotr M, Wysocki M, Budzyński A, et al. Enhanced recovery after bariatric surgery: systematic review and meta-analysis. Obes Surg 2017;27:226-35.
66. Aminian A, Brethauer SA, Andalib A, Nowacki AS, Jimenez A, et al. Individualized metabolic surgery score: procedure selection based on diabetes severity. Ann Surg 2017;266:650-7.
67. The Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) risk/benefit calculator. Available from: https://asmbs.org/resources/bariatric-surgical-risk-benefit-calculator [Last accessed on 27 Apr 2020].
